Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a novel coronavirus that has spread rapidly, resulting in a worldwide pandemic. Even though end-stage renal disease (ESRD) patients are particularly susceptible to COVID-19 infection and can develop severe to critical disease, there are limited studies and case reports about COVID-19 in ESRD patients. We report a case of a 63-year-old gentleman with ESRD on regular hemodialysis. We describe the clinical presentation of this patient, the diagnostic process, the laboratory and imaging investigations, as well as the course of treatment. He positively responded to a 14-day course of Lopinavir-Ritonavir, Ribavirin, Azithromycin, and Hydroxychloroquine.
【저자키워드】 COVID-19, coronavirus, Hemodialysis, 【초록키워드】 Treatment, Coronavirus disease 2019, Azithromycin, diagnostic, Infectious disease, Case report, Novel coronavirus, Laboratory, Spread, COVID-19 infection, Patient, End-stage renal disease, patients, ESRD, Critical disease, worldwide pandemic, susceptible, Course, resulting, develop, caused,